Foyston, Gordon, & Payne Inc Becton Dickinson & CO Transaction History

Foyston, Gordon, & Payne Inc

$388 Million
Q1 2025

A detailed history of Foyston, Gordon, & Payne Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Foyston, Gordon, & Payne Inc holds 54,082 shares of BDX stock, worth $9.16 Million. This represents 3.19% of its overall portfolio holdings.

Number of Shares

54,082

Previous 47,007 15.05%

Holding current value

$9.16 Million

Previous $10.7 Million 16.17%

% of portfolio

3.19%

Previous 2.91%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$222.79 - $249.08 $1.58 Million - $1.76 Million	7,075 Added 15.05%	54,082 $12.4 Million
Q4 2024 Feb 14, 2025	SELL	$220.02 - $243.75 $124,311 - $137,718	-565 Reduced 1.19%	47,007 $10.7 Million
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $1.54 Million - $1.68 Million	-6,949 Reduced 12.75%	47,572 $11.5 Million
Q2 2024 Jul 30, 2024	BUY	$225.07 - $246.17 $3.98 Million - $4.35 Million	17,682 Added 48.0%	54,521 $12.7 Million
Q1 2024 May 07, 2024	SELL	$233.45 - $247.73 $273,369 - $290,091	-1,171 Reduced 3.08%	36,839 $9.12 Million
Q4 2023 Feb 07, 2024	SELL	$232.24 - $267.23 $179,521 - $206,568	-773 Reduced 1.99%	38,010 $9.27 Million
Q3 2023 Oct 26, 2023	BUY	$254.9 - $283.59 $424,153 - $471,893	1,664 Added 4.48%	38,783 $10 Million
Q2 2023 Aug 01, 2023	BUY	$238.39 - $265.32 $1.54 Million - $1.71 Million	6,457 Added 21.06%	37,119 $9.8 Million
Q1 2023 May 03, 2023	SELL	$229.71 - $259.35 $95,559 - $107,889	-416 Reduced 1.34%	30,662 $7.59 Million
Q4 2022 Feb 09, 2023	BUY	$218.29 - $256.91 $4.01 Million - $4.72 Million	18,389 Added 144.92%	31,078 $7.91 Million
Q3 2022 Nov 04, 2022	BUY	$51.03 - $264.23 $4,745 - $24,573	93 Added 0.74%	12,689 $2.83 Million
Q2 2022 Aug 11, 2022	SELL	$234.74 - $275.42 $801,402 - $940,283	-3,414 Reduced 21.32%	12,596 $3.11 Million
Q1 2022 Apr 27, 2022	BUY	$243.64 - $270.48 $354,008 - $393,007	1,453 Added 9.98%	16,010 $4.26 Million
Q4 2021 Feb 11, 2022	SELL	$230.08 - $250.94 $127,924 - $139,522	-556 Reduced 3.68%	14,557 $3.66 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $755,641 - $832,758	3,247 Added 27.36%	15,113 $3.72 Million
Q2 2021 Aug 06, 2021	SELL	$232.65 - $254.58 $23,730 - $25,967	-102 Reduced 0.85%	11,866 $2.89 Million
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $280,132 - $310,054	-1,207 Reduced 9.16%	11,968 $2.91 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $168,215 - $186,422	-758 Reduced 5.44%	13,175 $3.3 Million
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $1.65 Million - $2.11 Million	7,633 Added 121.16%	13,933 $3.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	6,300	6,300 $1.23 Million

Others Institutions Holding BDX

# of Institutions

1,806

Shares Held

257M

Call Options Held

3.24M

Put Options Held

841K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $48.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.

Account

Foyston, Gordon, & Payne Inc Becton Dickinson & CO Transaction History